The new biology has the potential to provide mechanistic insights into the causes and progression of complex cardiopulmonary diseases such as congenital heart disease and bronchopulmonary dysplasia. Such research requires collaborative investigation supported by sophisticated infrastructures and core facilities. Translating basic observations to clinical outcomes will require networks for collaborative translational research. The research initiatives require excellently trained and motivated clinicianscientists, but there are numerous barriers to the training and support of clinician-scientists in cardiology and neonatology.
Cardiopulmonary morbidities are a significant fraction of neonatal disease and are a major part of the clinical care given to infants. We must match our research and training goals to the general societal goals of decreasing morbidities, improving disease-specific mortality and decreasing overall infant mortality. Two facts about infant mortality are striking: although the overall infant mortality decreased to 6.8 per 1000 in the US in 2001, this rate exceeds that of 25 other countries, and there is a large racial disparity with an infant mortality of 14 per 1000 in black infants. 1 The delivery trends do not favor improving outcomes. In the US, the rates of preterm births, multiple births and higher order multiple births are increasing. Lung-related problems contribute to about 20% of deaths and the combination of circulatory diseases and congenital malformations, which often include heart abnormalities, account for about 24% of infant mortality. 1 The number of very low birth weight infants with the highest morbidities and mortalities are increasing and, although their gestation-adjusted mortalities are decreasing, their morbidities are not. 2 The poor neurodevelopmental outcomes in very preterm infants must be a major research focus, and these outcomes correlate with cardiopulmonary abnormalities.
Opportunities for lung research
The application of the technical and conceptual revolution in biological sciences to neonatal problems is essential for significant progress. The integrated development of model systems in mice and other vertebrates that link genomic databases with phenotypes will provide the developmental information essential for understanding disease pathogenesis. New insights into developmental and pathogenic processes should result in new therapies and clinical care strategies. Research areas particularly relevant to the newborn lung are highlighted in Table 1 . Specific opportunities include the development of new approaches to induced lung maturation to decrease RDS, and the understanding of injury and repair in the preterm lung to better avoid and treat bronchopulmonary dysplasia. 3 An example of recent successes using genetic approaches is the identification of deficiencies resulting in the RDS phenotype in term infants. Surfactant protein B deficiency was first reported in 1997, 4 followed by the identification of a spectrum of interstitial lung diseases caused by surfactant protein C deficiency first reported in 2001. 5 Recently, the ABCA3 transporter was identified in a number of term infants with lethal RDS. 6 The identification of single gene deficiency lung diseases in infants will continue to increase an understanding of these rare causes of lung disease. More complex genetic relationships resulting from genetic and environmental modifiers will be required to explain susceptibilities to more common diseases such as BPD. Opportunities for cardiovascular research Some research priorities for cardiovascular research are listed in Table 2 . Congenital heart disease is the major category of cardiovascular problems leading to neonatal morbidity and mortality. 1 Presently, most clinical and research efforts are directed toward diagnosis and surgical treatment of congenital heart disease. This biophysical model of congenital heart disease focuses on anatomic diagnostic techniques, evaluations for other anomalies, and surgical repair, which provides no information about cause. Molecular and genetic models of congenital heart disease emphasize cause with the anticipation of prevention. For example, six different genetic abnormalities are associated with about 30% of cases of tetralogy of Fallot. 7 New research is needed to better characterize cardiac function in newborns. A special emphasis needs to be on heart function, organ blood flow and the diagnosis and treatment of low blood pressure in very low birth weight infants. The patent ductus arteriosis is often difficult to manage clinically in VLBW infants and these fragile infants often do not tolerate surgery well. A better understanding of mechanisms regulating ductal patency may result in improved pharmacologic approaches with less risk. A major area of research will be to explore if prematurity per se or specific neonatal diseases or antenatal exposures can program the individual to increase the risks of diseases such as heart attack, stroke and diabetes in later life. 8 
Resources needed
Much of the developmental and genetic research needed to explain the pathophysiology of lung and heart diseases in newborns requires highly sophisticated technology using multiple genetic, molecular, and physiologic approaches. Skilled investigators working in collaborative groups in environments with complex infrastructural support and core technologic facilities are essential for exploring the mechanisms of disease. As therapies are targeted to smaller groups of patients with less common diseases, clinical research networks will be essential to develop and test new therapies. A specific need is for a consortium of centers to collect lung tissue on survivors of BPD who later die for incidental reasons to develop information about how the vascular and alveolar abnormalities resolve with growth. Consortiums are also needed to collect DNA, cells and clinical information for infrequent problems that likely have a genetic basis, such as RDS in term infants. Similarly, networks to uniformly collect clinical information and biological materials from families with congenital heart disease will facilitate studies of cause and ultimately therapy.
Training research neonatologists and cardiologists for the future
The challenges are to train a select group of subspecialist clinicians to direct and translate the molecular and genomic research for the development of new treatments to improve outcomes of infants. There are a number of barriers that inhibit pediatricians in neonatology and cardiology subspecialty training from entering and continuing research careers ( Table 3 ). The science that must be applied to neonatal problems is complex and seminal observations often are not immediately obvious or applicable in a clinical context. The research is removed conceptually from clinical training and requires different skills and a different language to communicate. Projects will often need to be collaborative and utilize multiple techniques with access to core facilities, which complicates the development of research independence. Clinical translational research is becoming more difficult because of regulations and its multicenter nature. The increased complexity of the science makes it more difficult to engage new investigators and to develop careers.
Another problem is the increased complexity of clinical training. Clinical training for subspecialty certification is longer than in the past and clinical care is more complex and demanding. The increased requirements for faculty supervision and the increased bureaucracy of clinical care interfere with faculty mentorship of research training and early career development. 9 The reality is that clinical training requires more time, more energy and generates more frustration. Work rules that limit hours in training will almost certainly take a toll on the time available for scientific training. The changes in fellowship training that were recently approved by the American Board of Pediatrics will increase the flexibility of training programs and offer more opportunities for research during residency training. 10 However, there seems to be no solution to the increased complexities of clinical care that inevitably interfere with research activities. Nevertheless, research trained subspecialists are essential to the development of improved care strategies for newborns.
As has been well recognized, the initiation of a research career after medical school, residency and perhaps a year of subspecialty training is a very late start. Many successful research physicians were interested in and involved in science much earlier in their training careers. A late start is further complicated by social changes in pediatrics that emphasize family and work schedules. At a time when the science training needed to contribute to improving outcomes for infants is more demanding and clinical training is more complex, the choice of a life style that de-emphasizes hard work will result in academic failure. Life style choices of many subspecialty trainees are reinforced by salary differentials between clinical and academic positions and high debts resulting from medical education. Subspecialists in training must be exceptionally motivated and scientifically well educated to participate in innovative research to improve newborn outcomes.
